Skip to main content
SpringerLink
Log in

Challenges of post-approval studies in assessing ADRs

  • Clinical study
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Notes

  1. sponsored/funded by Cephalon (Teva Branded Pharmaceutical Products R&D).

Reference

  • Gavrielov-Yusim N, et al. Challenges of post-authorization safety studies: Lessons learned and results of a French study of fentanyl buccal tablet. Pharmacoepidemiology and Drug Safety : [7 pages], 13 Oct 2017. Available from: URL: http://dx.doi.org/10.1002/pds.4331

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Challenges of post-approval studies in assessing ADRs. Reactions Weekly 1675, 5 (2017). https://doi.org/10.1007/s40278-017-37773-9

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-017-37773-9

Search

Navigation